Latest Forte News & Updates

See the latest news and media coverage for Forte. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Forte

On-chain compliance and economic tools provider

forte.io
Headquarters
San Francisco, United States
Founded year
2018
Company type
Private company
Number of employees
10–400

Last updated

Latest news about Forte

In short: Forte across multiple separate entities underwent name changes, leadership appointments, and launched new payment infrastructure for blockchain.

Company announcements

  • Forte

    Forte announces Forte Pay integration with Etherlink

    It powers the tokenized marketplace on Etherlink and provides fiat-to-USDC conversion, KYC/AML, familiar in-game checkout, and low-cost EVM-compatible Tezos settlement.

  • Forte

    Forte launches Forte Pay on Soneium

    It provides enterprise-ready payments infrastructure enabling global card, local-currency, and crypto transactions, plus compliance, risk management, NFT checkout, and plug-and-play rails for developers.

  • Forte

    Forte makes FortePay the core payments for SequencePay

    Through a strategic alliance with Sequence, Forte offers end-to-end, multi-chain payments with fiat↔crypto conversion, card and crypto purchases, built-in KYC, global payment options, and optimized UX.

  • Forte

    Forte analyzes crypto's influence on the 2024 US election

    It examines candidates' crypto positions, industry political spending, and implications for regulation such as FIT21 and SEC leadership.

Unlock all announcements with a

Media coverage

  • BNN Bloomberg

    Forte Minerals Graduates to OTCQX® Best Market

    Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQX: FOMNF) (Frankfurt: 2OA) is pleased to announce that it commences trading today on the OTCQX...

  • AP News

    Forte Biosciences Announces Pricing of $150 Million Public Offering

    Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a public offering of ...

  • Investing.com

    Guggenheim reiterates Forte Biosciences stock rating ahead of data By Investing.com

    Guggenheim reiterated a Buy rating and $75.00 price target on Forte Biosciences Inc. (NASDAQ:FBRX) a...

  • Yahoo Finance

    Forte Biosciences, Inc. Announces 2025 Results and Provides Update

    Forte Biosciences, Inc. ( (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its full year 2025 financial results and...

Unlock all articles with a

Never miss news about Forte

Track Forte and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.